Printer Friendly
The Free Library
4,478,241 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Building bridges.


UCLA last week played host to 13 of China's top neurologists and psychiatrists who were here to learn how to establish Alzheimer's disease research centers in their own communities.

The three-day trip, paid for by Japanese drug maker Eisai Pharmaceuticals Inc., immersed the visiting scientists in U.S.-style research site management and techniques in conducting clinical trials, patient assessments, imaging technology, and quality assurance. The visitors also got a taste of some Hollywood-style hospitality, courtesy of a significant university benefactor.

UCLA's Dr. Jeffrey Cummings, one of the nation's top neurology researchers, had earlier in the day shown off facilities at the Deane F. Johnson Center for Neurotherapeutics, the neurological research institute he heads.

The center was endowed by Kate Edelman Johnson, who formed the Deane F. Johnson Alzheimer's Research Foundation after the 1999 death of the entertainment industry attorney and executive. She invited the group to dinner at her Beverly Hills home overlooking the UCLA campus, repaying the doctors for hospitality she was shown during a foundation-related trip to China last year.

Johnson said one of her dreams is for the center to focus on clinical trials leading to cures. "Deane was such a vibrant, active renaissance man." she said, noting her husband was diagnosed with Alzheimer's seven years before his death at age 81. "To watch him lose himself was heartbreaking."

The center specializes in conducting clinical trials for novel therapies for diseases ranging from Alzheimer's to Parkinson's disease. Most the studies are funded by the National Institutes for Health, but Cummings does have a few drug industry contracts, including a Novartis AG study of a patch-administered drug that could alleviate the deterioration in cognitive abilities that can accompany Parkinson's.

"I think we've established ourselves as a great research institution in only a short amount of time," said Johnson, noting that one strength is the close professional partnership she's developed with Cummings, who treated her husband in his final years. "I dream it; he makes it happen."

Center staff workers are now talking with a number of potential corporate sponsors, looking for ongoing annual gift that would help fund $125,000 in staff costs.

Staff reporter Deborah Crowe can be reached at (323) 549-5225, ext. 232, or at dcrowe@labusinessjournal.com.

COPYRIGHT 2006 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:HEALTH CARE & BIOTECH
Comment:Building bridges.(University of California Los Angeles plays host to chinese neurologists and psychiatrists )
Author:Crowe, Deborah
Publication:Los Angeles Business Journal
Geographic Code:1U9CA
Date:Nov 20, 2006
Words:373
Previous Article:Amgen looks to Asia for testing opportunities, partners.(HEALTH CARE & BIOTECH)
Next Article:This & that.(University of California Los Angeles approves additional funds for Ronald Reagan Medical Center )(Brief article)
Topics:



Related Articles
The biotech paradigm. (biotechnology industry) (CE Roundtable) (Panel Discussion)
HMO-biotech partnerships failing to materialize. (Los Angeles County, California)(Special Report: Health Care)
On the mend.
Tech Funds Look Like Slackers Compared to Biotech.(Brief Article)(Statistical Data Included)
Biotech balance: mutual fund diversification lets investors temper biotech's risk.(Mutual Fund Focus)
Ad firm moves west to target health care.(Media & Technology)(Brief Article)
Brooklyn's new website helps Nostrand Avenue renaissance.(TECHNOLOGY)(Brooklyn Economic Development Corporation)
Bridging gaps in wornd care: next month's conference of the New Zealand Wound Care Society has attracted an impressive range of national and...
Many healthy returns: healthcare funds may be the right prescription for long-term stock market success.(MUTUAL FUND FOCUS)
BRIEFLY.(General News)(REGION)

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles